Meng Ning | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Forensic Scientist

Dr. Meng Ning | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Chiba University | China

Dr. Meng Ning is an accomplished researcher at Chiba University, Japan, recognized for her pioneering work in the epigenetic regulation of cancer. She has made substantial contributions to understanding the non-catalytic roles of chromatin regulators, particularly in gastric cancer. Her expertise bridges molecular biology and clinical gastrointestinal oncology, enabling her to translate laboratory discoveries into potential therapeutic strategies. Meng Ning is known for her meticulous experimental design, innovative application of genome-editing technologies, and dedication to advancing cancer research through both independent studies and collaborative projects.

Professional Profile

ORCID

Education

Dr. Meng Ning completed her doctoral studies at Chiba University, Japan, where she focused on elucidating novel mechanisms of cancer progression. Her Ph.D. research revealed a previously unrecognized non-catalytic function of SETD1A in gastric cancer via the E2F4–TAF6 axis. Employing advanced techniques including transcriptomics, epigenomics, and genome-editing approaches, she was able to demonstrate this mechanism independently of traditional methyltransferase activity. Her academic training combines rigorous laboratory research with a strong foundation in clinical oncology, preparing her to conduct translational studies that link fundamental discoveries with therapeutic potential.

Experience

Dr. Meng Ning has extensive experience in both experimental and translational cancer research. She has collaborated with the Department of Pathology at the University of Tokyo to analyze clinical gastric cancer specimens, integrating molecular findings with patient data. Her work spans NGS-based studies, CRISPR genome editing, and multi-omics analyses, reflecting a versatile approach to cancer biology. Beyond laboratory research, she has contributed to the mentorship of junior researchers, participated in collaborative projects across institutions, and actively engaged in the scientific community through professional society memberships and research networks.

Research Interests

Dr. Meng Ning’s primary research interest lies in the epigenetic regulation of cancer, with a focus on non-catalytic functions of chromatin regulators. She investigates how these regulators influence tumor proliferation, cellular signaling, and transcriptional networks using advanced molecular biology techniques. Her research integrates next-generation sequencing, genome editing, and integrative bioinformatics to identify novel mechanisms underlying cancer progression. By connecting these molecular insights with clinical oncology, she aims to identify potential therapeutic targets and contribute to the development of innovative cancer treatments.

Awards

Dr. Meng Ning is nominated for the Best Researcher Award in recognition of her outstanding contributions to cancer epigenetics and translational oncology. Her research has introduced novel concepts in understanding chromatin regulator function and tumor biology, demonstrating originality, technical excellence, and significant impact in the field. Her dedication to advancing cancer research through rigorous experimentation and collaborative endeavors positions her as a leading researcher in her discipline.

Publications

Dr. Meng Ning has authored several high-impact, SCI-indexed publications as first or contributing author. Her work demonstrates innovative methodologies and deep insights into the molecular mechanisms of cancer:

Title: Non-catalytic role of SETD1A promotes gastric cancer cell proliferation through the E2F4–TAF6 axis in the cell cycle
Journal: Cell Death & Disease
Published on: 2025-08-23

Title: Non-enzymatic SETD1A activity drives breast cancer cell proliferation via cyclin K
Journal: Breast Cancer Research
Published on: 2025-08-11

Title: Integrated enhancer regulatory network by enhancer–promoter looping in gastric cancer
Journal: NAR Cancer
Published on: 2024-04-08

Conclusion

Dr. Meng Ning exemplifies excellence in scientific research through her innovative studies in cancer epigenetics and her commitment to translational application. Her work bridges basic molecular discoveries and clinical oncology, offering new avenues for therapeutic development. With a combination of technical skill, collaborative engagement, and visionary research, Meng Ning stands out as a highly deserving candidate for the Best Researcher Award. Her contributions not only advance the understanding of cancer biology but also inspire ongoing innovation in epigenetic and translational research.

Nicolas Leuenberger | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Forensic Scientist

Dr. Nicolas Leuenberger | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Swiss laboratory for Doping Analyses | Switzerland

Dr. Nicolas Leuenberger is a distinguished Privat-docent and Research Manager at the Swiss Laboratory for Doping Analyses, University Hospital of Lausanne. With a proven track record in forensic science and anti-doping research, he has contributed significantly to advancing methodologies for detecting blood doping and other performance-enhancing practices. His leadership in managing research projects, mentoring graduate students, and fostering international collaborations has positioned him as an influential figure in forensic and biomedical sciences.

Professional Profile

Scopus

Education

Dr. Nicolas Leuenberger holds a PhD in Biomedical Sciences and advanced qualifications in forensic and medical sciences, which laid the foundation for his career in anti-doping research. His academic background integrates molecular biology, biochemistry, and forensic medicine, enabling him to explore novel biomarkers of blood manipulation and enhance anti-doping practices worldwide.

Experience

With extensive experience as Research Manager at the Swiss Laboratory for Doping Analyses, Dr. Nicolas Leuenberger oversees both research operations and biological unit management. He directs master’s and PhD projects, guiding students from experimental design to thesis completion. As part of the LAD management team, he coordinates grant applications, establishes ISO-accredited protocols, and supervises multidisciplinary collaborations with hospital units and global anti-doping laboratories. His consultancy roles with Novartis Pharma Schweiz AG, the Research Grants Council of Hong Kong, and the World Anti-Doping Agency further demonstrate his expertise and international recognition.

Research Interests

Dr. Nicolas Leuenberger’s research focuses on the discovery of innovative biomarkers for blood doping, particularly through the fields of ironomics and transcriptomics. His pioneering work on erythroferrone and hepcidin as indicators of blood manipulation has reshaped anti-doping science. Currently, he is advancing mRNA biomarker detection from dried blood spots, enabling more accurate detection of autologous blood transfusions and micro-dose EPO administration. His commitment lies in developing cutting-edge forensic tools that safeguard the integrity of sports and public health.

Awards

Dr. Nicolas Leuenberger has been widely recognized for his contributions to forensic and anti-doping science. His editorial appointment as Associate Editor of Frontiers in Sport and Active Living and his membership in the Swiss Haematology Society underscore his professional standing. He has also been invited as an expert reviewer for the World Anti-Doping Agency and other international bodies, reflecting his global impact on anti-doping policy and scientific innovation.

Publications

Dr. Nicolas Leuenberger has authored over 45 peer-reviewed publications in leading scientific journals, significantly contributing to anti-doping and forensic biomarker research. A selection of his highly cited works includes:

1. Detection of erythropoiesis-stimulating agents in human anti-doping control: Past, present and future
Journal: Drug Testing and Analysis
Published on: July 2012

2. Circulating microRNAs as Biomarkers for Detection of Autologous Blood Transfusion
Journal: PLoS ONE
Published on: June 2013

3. Circulating microRNAs: The Future of Biomarkers in Anti-doping Field
Journal: Drug Testing and Analysis
Published on: December 2015

4. Autologous Blood Transfusion in Sports: Emerging Biomarkers
Journal: Transfusion Medicine Reviews
Published on: May 2016

5. mRNA Biomarkers in Dried Blood Spots May Improve Detection of Autologous Blood Micro-Transfusions Using an Individualized Approach
Journal: Haematologica
Published on: August 2025

6. High Pretransplant Levels of Erythroferrone Are Predictive for 1-Year All-Cause Mortality and Acute Cellular Rejection after Heart Transplantation
Journal: The Journal of Heart and Lung Transplantation
Published on: January 2025

7. New Transcriptomic Biomarkers for Detection of the Recombinant Human Erythropoietin (rHuEPO) MirCERA in Horses
Journal: Frontiers in Veterinary Science
Published on: September 2024

8. Comparison between standard hematological parameters and blood doping biomarkers in dried blood spots within the athlete population of Swiss Sport Integrity
Journal: Haematologica
Published on: September 2024

Conclusion

Dr. Nicolas Leuenberger exemplifies scientific excellence through his pioneering research in anti-doping biomarker discovery, his leadership at the Swiss Laboratory for Doping Analyses, and his dedication to mentoring the next generation of forensic scientists. His contributions have not only advanced the global fight against blood doping but also strengthened the integrity of competitive sports. For these reasons, he is a highly deserving candidate for the Best Researcher Award.

Shivkant Sharma | Genetics | Best Researcher Award

Published on by Forensic Scientist

Dr. Shivkant Sharma | Genetics | Best Researcher Award

Research Scientist | Ingenomics Private Limited | India

Dr. Shivkant Sharma is a dedicated Research Scientist at Ingenomics Private Limited, New Delhi, India. With a profound background in forensic science and genetics, his expertise spans forensic DNA analysis, population genetics, molecular biology, and quality control in laboratory settings. His contributions to forensic research and genetic diversity studies have been widely recognized.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

  • Extensive Research Experience: Dr. Sharma has a robust background in forensic genetics, population studies, and molecular biology, with experience spanning roles as a Research Scientist, Application Scientist, and Forensic DNA Examiner.
  • Notable Publications: He has contributed to numerous peer-reviewed journals, showcasing a consistent research output in population genetics, forensic science, and Y-Chromosomal STR diversity.
  • Specialized Skills and Techniques: Hands-on expertise in DNA isolation, multiplex PCR, real-time PCR, next-generation sequencing (NGS), and statistical data analysis positions him as a technical authority in his field.
  • Quality Control and Regulatory Contributions: His role in securing ISO18385 certification demonstrates his commitment to maintaining high laboratory standards and ensuring regulatory compliance.
  • Collaboration and Data Contribution: Contributions to global databases like YHRD enhance the accessibility and impact of his research.
  • Educational Background and Certifications: His Ph.D. on Y-Chromosomal STR diversity in Indian Brahmin populations and multiple certifications (e.g., ISO/IEC 17025, AICEF DNA Proficiency Tests) solidify his academic and technical credentials.

🎓 Education

Dr. Sharma earned his Ph.D. in Forensic Science from Maharshi Dayanand University, Rohtak, Haryana, with his thesis titled “A Cross-Sectional Study on Genetic Diversity of Y-Chromosomal STRs in Brahmin Population of Haryana and Rajasthan, India.” He holds an M.Sc. in Forensic Science from the same university, specializing in Forensic Chemistry and Toxicology, with a dissertation on poisoning cases in Himachal Pradesh. He also completed his B.Sc. in Medical Sciences from Maharshi Dayanand University.

💼 Experience

Dr. Sharma’s career includes roles such as:

  • Research Scientist (April 2024 – Present) at Ingenomics Private Limited, Delhi, where he has been instrumental in developing ISO18385 certification, performing forensic DNA analysis, and conducting population genetics studies.
  • Application Scientist (Oct. 2022 – March 2024) at BioZed Research and Testing Laboratories, Delhi, where he supported forensic laboratories in India, focusing on STR kits and collaborative population genetic studies.
  • Forensic DNA Examiner (2019 – 2021) at the DNA Division of DFS Junga, Shimla Hills, HP, where he assisted in analyzing crime scene evidence and worked in Disaster Victim Identification.

🔬 Research Interests On Genetics

Dr. Sharma’s research interests include:

  • Genetics
  • Genetic Genealogy
  • Y-Chromosome Studies
  • Population Genetics
  • Molecular Biology

🏆 Awards

  • Seventeenth Asian-Indo Pacific AICEF-GITAD DNA Proficiency Test (2023), AICEF, Spain
  • Sixteenth Asian-Indo Pacific AICEF-GITAD DNA Proficiency Test (2022), AICEF, Spain
  • ISO/IEC 17025: 2017 Certification, Quality Council of India (QCI)
  • UGC-NET Qualification for Assistant Professor (2014), Forensic Science

📖 Publications

  • Title: Contraceptive knowledge, attitude and practice among eligible couples of rural Haryana
    Authors: N Saluja, S Sharma, S Choudhary, D Gaur, S Pandey
    Year: 2011
    Citations: 87

  • Title: A study on knowledge and awareness of cervical cancer among females of rural and urban areas of Haryana, North India
    Authors: L Kadian, G Gulshan, S Sharma, I Kumari, C Yadav, S Nanda, R Yadav
    Year: 2021
    Citations: 43

  • Title: Dietary patterns, nutrition knowledge and lifestyle: associations with blood pressure in a sample of Australian adults (the Food BP study)
    Authors: S Khalesi, S Sharma, C Irwin, J Sun
    Year: 2016
    Citations: 36

  • Title: Antimicrobial susceptibility pattern & biotyping of Helicobacter pylori isolates from patients with peptic ulcer diseases
    Authors: S Sharma, KN Prasad, D Chamoli, A Ayyagari
    Year: 1995
    Citations: 29

  • Title: Tomato red toxicity: haematological and serological changes in the blood of Swiss albino mice, mus musculus
    Authors: S Sharma, RP Goyal, G Chakravarty, A Sharma
    Year: 2006
    Citations: 24

  • Title: Trend of complete hydatidiform mole
    Authors: K Thapa, M Shrestha, S Sharma, S Pandey
    Year: 2010
    Citations: 18

  • Title: Toxicological studies on effect of Apple Green-a permitted food colour, on swiss albino mice
    Authors: A Sharma, RP Goyal, G Chakravarty, S Sharma
    Year: 2006
    Citations: 15

  • Title: Orange red, a blend of permitted food colour induced haematological changes in Swiss albino mice, Mus musculus
    Authors: S Sharma, RP Goyal, G Chakravarty, A Sharma
    Year: 2005
    Citations: 15

  • Title: Aberrant promoter methylation of NOTCH1 and NOTCH3 and its association with cervical cancer risk factors in North Indian population
    Authors: LK Kadian, G Gulshan, P Ahuja, G Singhal, S Sharma, S Nanda, R Yadav
    Year: 2020
    Citations: 13

  • Title: Identification and genetic characterization of chikungunya virus from Aedes mosquito vector collected in the Lucknow district, North India
    Authors: N Nyari, HS Maan, S Sharma, SN Pandey, TN Dhole
    Year: 2016
    Citations: 13

📄 Conclusion

Dr. Shi Vkant Sharma is a distinguished researcher whose work in forensic science, population genetics, and molecular biology has significantly contributed to the understanding of genetic diversity in India. His expertise, combined with a passion for forensic innovation, continues to drive impactful research and development in the field.